Dbl-Blind, Rand Phase 1/2a Human Challenge Study, to Eval Safety, Reactognty, Immunognty and Preliminary Efficacy After Sporozoite Challenge/Rechallenge of Vaccines Containing RTS,S.

Trial Profile

Dbl-Blind, Rand Phase 1/2a Human Challenge Study, to Eval Safety, Reactognty, Immunognty and Preliminary Efficacy After Sporozoite Challenge/Rechallenge of Vaccines Containing RTS,S.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 17 Jun 2014

At a glance

  • Drugs GSK 257049 (Primary)
  • Indications Malaria
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 12 Jan 2010 Actual end date (Jan 2006) added as reported by ClinicalTrials.gov.
    • 01 Aug 2009 Results published in the Journal of Infectious Diseases.
    • 26 Jul 2007 The expected completion date for this trial is now 1 Jan 2006.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top